320 related articles for article (PubMed ID: 11972891)
1. Cyclosporine decreases skin lesions and pruritus in dogs with atopic dermatitis: a blinded randomized prednisolone-controlled trial.
Olivry T; Rivierre C; Jackson HA; Murphy KM; Davidson G; Sousa CA
Vet Dermatol; 2002 Apr; 13(2):77-87. PubMed ID: 11972891
[TBL] [Abstract][Full Text] [Related]
2. Randomized controlled trial of the efficacy of cyclosporine in the treatment of atopic dermatitis in dogs.
Olivry T; Steffan J; Fisch RD; Prélaud P; Guaguère E; Fontaine J; Carlotti DN;
J Am Vet Med Assoc; 2002 Aug; 221(3):370-7. PubMed ID: 12164533
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of cyclosporine A in cats with presumed atopic dermatitis: a double blind, randomised prednisolone-controlled study.
Wisselink MA; Willemse T
Vet J; 2009 Apr; 180(1):55-9. PubMed ID: 18294881
[TBL] [Abstract][Full Text] [Related]
4. A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs.
Little PR; King VL; Davis KR; Cosgrove SB; Stegemann MR
Vet Dermatol; 2015 Feb; 26(1):23-30, e7-8. PubMed ID: 25496303
[TBL] [Abstract][Full Text] [Related]
5. Clinical trial evaluating the efficacy and safety of cyclosporine in dogs with atopic dermatitis.
Steffan J; Parks C; Seewald W;
J Am Vet Med Assoc; 2005 Jun; 226(11):1855-63. PubMed ID: 15934253
[TBL] [Abstract][Full Text] [Related]
6. Long-term use of cyclosporine in the treatment of canine atopic dermatitis.
Radowicz SN; Power HT
Vet Dermatol; 2005 Apr; 16(2):81-6. PubMed ID: 15842537
[TBL] [Abstract][Full Text] [Related]
7. A randomised controlled trial testing the rebound-preventing benefit of four days of prednisolone during the induction of oclacitinib therapy in dogs with atopic dermatitis.
Olivry T; Lokianskiene V; Blanco A; Mestre PD; Bergvall K; Beco L
Vet Dermatol; 2023 Apr; 34(2):99-106. PubMed ID: 36330780
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of a 0.0584% hydrocortisone aceponate spray in the management of canine atopic dermatitis: a randomised, double blind, placebo-controlled trial.
Nuttall T; Mueller R; Bensignor E; Verde M; Noli C; Schmidt V; Rème C
Vet Dermatol; 2009 Jun; 20(3):191-8. PubMed ID: 19374721
[TBL] [Abstract][Full Text] [Related]
9. Concurrent short-term use of prednisolone with cyclosporine A accelerates pruritus reduction and improvement in clinical scoring in dogs with atopic dermatitis.
Dip R; Carmichael J; Letellier I; Strehlau G; Roberts E; Bensignor E; Rosenkrantz W
BMC Vet Res; 2013 Sep; 9():173. PubMed ID: 24004561
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, placebo-controlled study to evaluate the effect of EFF1001, an Actinidia arguta (hardy kiwi) preparation, on CADESI score and pruritus in dogs with mild to moderate atopic dermatitis.
Marsella R; Messinger L; Zabel S; Rosychuck R; Griffin C; Cronin PO; Belofsky G; Lindemann J; Stull D
Vet Dermatol; 2010 Feb; 21(1):50-7. PubMed ID: 19843302
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of a new topical cyclosporine A formulation in the treatment of atopic dermatitis in dogs.
Puigdemont A; Brazís P; Ordeix L; Dalmau A; Fuertes E; Olivar A; Pérez C; Ravera I
Vet J; 2013 Aug; 197(2):280-5. PubMed ID: 23562341
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of oclacitinib (Apoquel®) compared with prednisolone for the control of pruritus and clinical signs associated with allergic dermatitis in client-owned dogs in Australia.
Gadeyne C; Little P; King VL; Edwards N; Davis K; Stegemann MR
Vet Dermatol; 2014 Dec; 25(6):512-8, e86. PubMed ID: 25109820
[TBL] [Abstract][Full Text] [Related]
13. Comparable efficacy of a topical 0.0584% hydrocortisone aceponate spray and oral ciclosporin in treating canine atopic dermatitis.
Nuttall TJ; McEwan NA; Bensignor E; Cornegliani L; Löwenstein C; Rème CA
Vet Dermatol; 2012 Feb; 23(1):4-10, e1-2. PubMed ID: 21718368
[TBL] [Abstract][Full Text] [Related]
14. Comparison of cyclosporine A with methylprednisolone for treatment of canine atopic dermatitis: a parallel, blinded, randomized controlled trial.
Steffan J; Alexander D; Brovedani F; Fisch RD
Vet Dermatol; 2003 Feb; 14(1):11-22. PubMed ID: 12603681
[TBL] [Abstract][Full Text] [Related]
15. A systematic review and meta-analysis of the efficacy and safety of cyclosporin for the treatment of atopic dermatitis in dogs.
Steffan J; Favrot C; Mueller R
Vet Dermatol; 2006 Feb; 17(1):3-16. PubMed ID: 16412115
[TBL] [Abstract][Full Text] [Related]
16. Prednisolone is associated with an increase in serum insulin but not serum fructosamine concentrations in dogs with atopic dermatitis.
Kovalik M; Thoday KL; Evans H; van den Broek AH; Mellanby RJ
Vet J; 2012 May; 192(2):212-6. PubMed ID: 21745752
[TBL] [Abstract][Full Text] [Related]
17. Pilot evaluation of the antipruritic efficacy of a topical transient receptor potential melastatin subfamily 8 (TRPM8) agonist in dogs with atopic dermatitis and pedal pruritus.
Tamamoto-Mochizuki C; Murphy KM; Olivry T
Vet Dermatol; 2018 Feb; 29(1):29-e14. PubMed ID: 28952176
[TBL] [Abstract][Full Text] [Related]
18. Single blinded, randomized, placebo-controlled study on the effects of ciclosporin on cutaneous barrier function and immunological response in atopic beagles.
White AG; Santoro D; Ahrens K; Marsella R
Vet Immunol Immunopathol; 2018 Mar; 197():93-101. PubMed ID: 29475513
[TBL] [Abstract][Full Text] [Related]
19. A blinded, randomized, placebo-controlled, dose determination trial of lokivetmab (ZTS-00103289), a caninized, anti-canine IL-31 monoclonal antibody in client owned dogs with atopic dermatitis.
Michels GM; Ramsey DS; Walsh KF; Martinon OM; Mahabir SP; Hoevers JD; Walters RR; Dunham SA
Vet Dermatol; 2016 Dec; 27(6):478-e129. PubMed ID: 27647569
[TBL] [Abstract][Full Text] [Related]
20. The glucocorticoid sparing efficacy of Phytopica in the management of canine atopic dermatitis.
Schmidt V; McEwan N; Volk A; Helps J; Morrell K; Nuttall T
Vet Dermatol; 2010 Feb; 21(1):96-105. PubMed ID: 20187915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
